A Retrospective Study on Therapeutic Efficacy of Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors Plus Lenvatinib in Patients With Unresectable Hepatocellular Carcinoma

Objective: We assessed the efficacy and safety of transarterial chemoembolization (TACE) in combination with lenvatinib plus programmed death receptor-1 (PD-1) signaling inhibitors (camrelizumab or sintilimab) in unresectable hepatocellular carcinoma (uHCC). Methods: In this retrospective study, pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Teng, Ying, Ding, Xiaoyan, Li, Wendong, Sun, Wei, Chen, Jinglong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943530/
https://www.ncbi.nlm.nih.gov/pubmed/35313780
http://dx.doi.org/10.1177/15330338221075174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943530/
https://www.ncbi.nlm.nih.gov/pubmed/35313780
http://dx.doi.org/10.1177/15330338221075174

Ejemplares similares